Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
01/26/2005 | CN1569207A Prescription for blackening hair and prolonging life and its preparation |
01/26/2005 | CN1569205A Method for preparing and controlling the quality of Chinese medicinal soft capsule |
01/26/2005 | CN1569202A Medicine for treating acne and preparation method thereof |
01/26/2005 | CN1569193A Medicine for treating burns and scalds and without scar after its healing |
01/26/2005 | CN1569188A Externally applied liquor for treating psoriasis |
01/26/2005 | CN1569175A Chinese medicine for treating burn and frostbite |
01/26/2005 | CN1569174A Chinese medicine for treating injury and wound |
01/26/2005 | CN1569134A Zinc oil preparation for treating burn and scald and preparation process thereof |
01/26/2005 | CN1569124A Medicine for treating scald and its preparing method |
01/26/2005 | CN1569111A Burn treating cream |
01/26/2005 | CN1569106A Medicine for treating psoriasis and its preparation method |
01/26/2005 | CN1569103A Medicinal bolus with functions of generating hair by tonifying kidney and replenishing essence |
01/26/2005 | CN1569091A Beautifying face pack of pure Chinese herb for preventing face skin disease |
01/26/2005 | CN1569083A Prescription of beautifying dietetic lozenge |
01/26/2005 | CN1569080A Natural Chinese herb composition for treating alopecia and leucotrichia and its application |
01/26/2005 | CN1569076A Dermatosis treating medicine |
01/26/2005 | CN1569072A Compound chinese medicinal oral preparation for treating alopecia areata and alopecia and its preparing method |
01/26/2005 | CN1569065A Medicine for treating piles and burns |
01/26/2005 | CN1569062A Acne treating medicine |
01/26/2005 | CN1569058A Innovative technique for processing aloe raw material with high stability |
01/26/2005 | CN1569038A Medicine for treating knife wound and other wounds and its preparation |
01/26/2005 | CN1569037A Medicine for treating burns and scalds and its preparation method |
01/26/2005 | CN1569036A Medicine for treating cindyloma acuminatum and its preparing process |
01/26/2005 | CN1569032A Cattle bone ash made burns treating medicine |
01/26/2005 | CN1569029A Medicine for treating recurrent psoriasis and its preparing process |
01/26/2005 | CN1569026A Medicine for preventing and treating chilblain and its preparation method |
01/26/2005 | CN1569025A Medicine for treating psoriasis and its preparation method |
01/26/2005 | CN1569020A Folliculitis dermatitis cream |
01/26/2005 | CN1569010A Etimicin sulfate preparation and its preparing method |
01/26/2005 | CN1568978A Composition for preventing and treating whelk |
01/26/2005 | CN1568973A Composition of vitamin C and arginine and its application |
01/26/2005 | CN1568967A Radiation resistant medicament of ginko flavone and tea polyphenol |
01/26/2005 | CN1568957A Reforming effect of arginine to recessive harm of skin tissue of diabetic |
01/26/2005 | CN1568935A Skin whitening compositions containing asparagus extract |
01/26/2005 | CN1568926A Pharmaceutical shampoo |
01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
01/26/2005 | CN1186090C Liquid medicine for treating burn |
01/26/2005 | CN1186079C Burn treating medicine powder |
01/26/2005 | CN1186077C Medicine for stopping pain, diminishing inflammation, removing necrosis and promoting granulation |
01/26/2005 | CN1186068C Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its preparation process |
01/26/2005 | CN1186055C Medicine for treating acne and preparing process thereof |
01/26/2005 | CN1186047C Externally applied psoriasis treating medicine and its preparation |
01/26/2005 | CN1186034C Chinese medicine for treating burn and scald |
01/26/2005 | CN1185957C Skin-care agent, health and face-care foodstuff |
01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
01/25/2005 | US6846837 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
01/25/2005 | US6846834 Antiinflammation agents |
01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
01/25/2005 | US6846821 Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors |
01/25/2005 | US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer |
01/25/2005 | US6846674 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and |
01/25/2005 | US6846499 Medical effect of jojoba oil |
01/25/2005 | US6846494 Aftertreatment surgery; mixture of protein, carbohydrates, fats, arginine, ascorbic acid, tocophenol and flavonoids |
01/25/2005 | US6846490 Enhance hydrophobicity of a biological surface by applying vernix and a dispersant |
01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
01/20/2005 | WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
01/20/2005 | WO2005006806A1 Wireless microphone communication system |
01/20/2005 | WO2005005383A1 Amino alcohol compound |
01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
01/20/2005 | WO2005004906A2 Use of dp iv and apn inhibitors for the treatment of dermatological diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts |
01/20/2005 | WO2005004894A2 Methods for increasing cell and tissue viability |
01/20/2005 | WO2005004891A2 Use of an antioxidant in a dermatological and/or cosmetic composition |
01/20/2005 | WO2005004858A1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
01/20/2005 | WO2005004856A1 Antifungal composition |
01/20/2005 | WO2005004829A1 Powdery compositions and skin preparation containing the same for external use |
01/20/2005 | WO2004106519A3 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids |
01/20/2005 | WO2004069213A3 Cosmetic composition comprising a 2-alkylideneaminooxyacetamide |
01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
01/20/2005 | US20050014803 Enzyme inhibitors |
01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
01/20/2005 | US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines |
01/20/2005 | US20050014731 Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds |
01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
01/20/2005 | US20050014699 Combinations of enzyme inhibitor-containing preparations and the use thereof |
01/20/2005 | US20050014696 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
01/20/2005 | US20050013877 Strontium compound for treatment of sub-dermal soft tissue pain |
01/20/2005 | US20050013873 Use of glass compositions for achieving an antioxidative effect |
01/20/2005 | US20050013858 Sustained release formulation; shorter treatment duration; higher tolerance; fungal infections |
01/20/2005 | US20050013852 Rapid release, water permeable self adhesive polymer matrix system; photodynamic therapy and/or diagnosis of skin lesions |
01/20/2005 | US20050013821 Mint extract and related pharmaceutical compositions |
01/20/2005 | DE10330243A1 Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis Use of products derived from extremophilic bacteria osmolytes for the production of drugs for external treatment of atopic dermatitis |
01/20/2005 | DE10327719A1 VEGFR-2 und VEGFR-3 Inhibitorische Anthranylamidpyridone VEGFR-2 and VEGFR-3 inhibitory Anthranylamidpyridone |
01/20/2005 | CA2838411A1 Methods of treating acne and rosacea with galvanic generated electricity |
01/20/2005 | CA2532828A1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
01/20/2005 | CA2531186A1 Use of an antioxidant in a dermatological and/or cosmetic composition |